Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Total Current Liabilities: 2009-2022

Historic Total Current Liabilities for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Sep 2022 value amounting to $41.5 million.

  • Avadel Pharmaceuticals' Total Current Liabilities rose 136.03% to $41.5 million in Q3 2022 from the same period last year, while for Sep 2022 it was $41.5 million, marking a year-over-year increase of 136.03%. This contributed to the annual value of $21.0 million for FY2021, which is 38.99% up from last year.
  • Per Avadel Pharmaceuticals' latest filing, its Total Current Liabilities stood at $41.5 million for Q3 2022, which was down 10.18% from $46.2 million recorded in Q2 2022.
  • Avadel Pharmaceuticals' 5-year Total Current Liabilities high stood at $87.2 million for Q1 2018, and its period low was $9.1 million during Q1 2021.
  • In the last 3 years, Avadel Pharmaceuticals' Total Current Liabilities had a median value of $23.0 million in 2020 and averaged $26.7 million.
  • In the last 5 years, Avadel Pharmaceuticals' Total Current Liabilities plummeted by 71.80% in 2021 and then skyrocketed by 382.71% in 2022.
  • Over the past 5 years, Avadel Pharmaceuticals' Total Current Liabilities (Quarterly) stood at $38.4 million in 2018, then dropped by 6.25% to $36.0 million in 2019, then plummeted by 58.01% to $15.1 million in 2020, then surged by 38.99% to $21.0 million in 2021, then surged by 136.03% to $41.5 million in 2022.
  • Its Total Current Liabilities was $41.5 million in Q3 2022, compared to $46.2 million in Q2 2022 and $44.0 million in Q1 2022.